Phase 2 Dose-Response Study Evaluating the Safety and Efficacy of NCX 470 vs Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Clinical trial NCT03657797 · COMPLETED
Trial details
- NCT number
- NCT03657797
- Sponsor
- Nicox Ophthalmics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-01
- Primary completion
- 2019-08-23
- Enrollment
- 656
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.